-
Morgan Keegan Raises PT On athenahealth To $49
Friday, February 18, 2011 - 10:03am | 27Morgan Keegan has raised the price target on athenahealth, Inc. (NASDAQ: ATHN) from $45 to $49 and maintains its Outperform rating.
-
Piper Jaffray Maintains Athenahealth Overweight, $49 PT (ATHN)
Friday, February 18, 2011 - 9:38am | 114Piper Jaffray maintained its Athenahealth (NASDAQ: ATHN) Overweight rating and $49 price target in a research report published today. In the report, Piper Jaffray states, "Athenahealth reported nice upside on Q4 results, with EPS of $0.28 vs. consensus of $0.20, and PJC estimate of $0.21. Revenue...
-
HMS Holdings Reports Q4 EPS of $0.43
Friday, February 18, 2011 - 8:40am | 56HMS Holdings Corp (NASDAQ: HMSY) reports its Q4 EPS at $0.43, versus the consensus of $0.42. HMSY reports its Q4 revenue at $87.2 million, versus the consensus of $85 million. HMSY shares gained 1.25% to close at $71.96 yesterday. Read more from Benzinga's Company news.
-
HMS Holdings Corp Reports Q4 EPS of $0.43 vs. $0.42
Friday, February 18, 2011 - 8:36am | 79HMS Holdings Corp. (NASDAQ: HMSY) today announced financial results for its fourth quarter and full year ended December 31, 2010. Revenue for the fourth quarter of 2010 increased 31.4% to $87.2 million, compared with $66.3 million for the same period a year ago. Net income increased 32.5% to $12.4...
-
Jefferies Lowers PT On CardioNet To $5
Friday, February 18, 2011 - 8:33am | 26Jefferies & Company has lowered the price target on CardioNet (NASDAQ: BEAT) from $6 to $5 and maintains its Hold rating.
-
Citi Gives Color On Express Scripts Following Earnings Conference Call
Friday, February 18, 2011 - 8:15am | 170Express Scripts (NASDAQ: ESRX) management surprised investors by noting that 2011 would be a more back-end loaded earnings year, with Q1-11 results coming in below Q4-10 at the EPS line. The consensus estimate was for $0.73, ahead of the $0.71 reported in Q4-10. The negative revision versus...
-
Jefferies Downgrades FMS To Hold
Friday, February 18, 2011 - 8:00am | 42Analysts at Jefferies downgrade Fresenius Medical Care AG & Co (NYSE: FMS) from “buy” to “hold.” FMS shares gained 0.95% to close at $65.10 yesterday. More Analyst Ratings here
-
CardioNet, Inc. Reports Q4 EPS of $(0.13) vs. $(0.15)
Thursday, February 17, 2011 - 5:16pm | 131CardioNet, Inc. (NASDAQ: BEAT) today reported results for the fourth quarter and full year-ended December 31, 2010. Revenues for the fourth quarter 2010 were $28.7 million, a decrease of 13.9% compared to $33.3 million in the fourth quarter 2009. On a GAAP basis, net loss for the fourth quarter...
-
Athenahealth Reporst Q4 EPS of $0.28 vs. $0.20
Thursday, February 17, 2011 - 5:08pm | 99athenahealth, Inc. (Nasdaq: ATHN) today announced financial and operational results for the fourth quarter. Total revenue for the three months ended December 31, 2010, was $69.4 million, compared to $54.4 million in the same period last year, an increase of 27%. For the three months ended December...
-
IntegraMed Reports Q4 EPS of $0.08 vs. $0.07
Thursday, February 17, 2011 - 9:44am | 41IntegraMed America, Inc. (NASDAQ: INMD) announced today results for the fourth quarter and year ended December 31, 2010 and also reported on progress in its vein clinics division expansion. Revenue: $63.8M Net Income: $890K EPS $0.08
-
Jefferies Raises PT On Express Scripts To $69
Thursday, February 17, 2011 - 9:26am | 27Jefferies & Company has raised the price target on Express Scripts (NASDAQ: ESRX) from $57.50 to $69 and maintains its Buy rating.
-
Express Scripts Reports Strong Fourth Quarter and Full Year 2010 Results
Wednesday, February 16, 2011 - 5:09pm | 173Express Scripts, Inc. (Nasdaq: ESRX) announced 2010 fourth quarter and full year net income from continuing operations of $329.6 million and $1,204.6 million, or $0.62 and $2.21 per diluted share, respectively. Adjusted earnings per share, as detailed in Table 4 were $0.71 and $2.50 per diluted...
-
Express Scripts Reports Q EPS of $0.62 vs. $0.70
Wednesday, February 16, 2011 - 5:04pm | 27Express Scripts, Inc. (Nasdaq: ESRX) announced 2010 fourth quarter and full year net income. Revenues $ 11,294.2M Net income $ 329.6M EPS $0.62
-
Quest Diagnostics Declares Dividend of $.10
Wednesday, February 16, 2011 - 4:08pm | 42Quest Diagnostics Incorporated (NYSE: DGX) today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on April 19, 2011, to shareholders of record of Quest Diagnostics common stock on April 5, 2011.
-
Calls Purchased on Medco Health Solutions (MHS)
Wednesday, February 16, 2011 - 11:53am | 146Shares of Medco Health Solutions (NYSE: MHS) are higher on the session by 2.10%, currently trading at $63.59. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today....